|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Srivatanakul P, Sriplung H and Deerasamee
S: Epidemiology of liver cancer: an overview. Asian Pac J Cancer
Prev. 5:118–125. 2004.
|
|
3
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marrero JA and Lok AS: Newer markers for
hepatocellular carcinoma. Gastroenterology. 127(Suppl 1):
S113–S119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jannot G and Simard MJ: Tumour-related
microRNAs functions in Caenorhabditis elegans. Oncogene.
25:6197–6201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng F, Henson R, Lang M, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Budhu A, Jia HL, Forgues M, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA, Ferracin M, Cimmino A, et al: A
MicroRNA signature associated with prognosis and progression in
chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo X, Burwinkel B, Tao S and Brenner H:
MicroRNA signatures: novel biomarker for colorectal cancer? Cancer
Epidemiol Biomarkers Prev. 20:1272–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative CT method. Nat
Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marrero JA, Feng Z, Wang Y, et al:
α-fetoprotein, des-γ carboxyprothrombin, and lectin-bound
α-fetoprotein in early hepatocellular carcinoma. Gastroenterology.
137:110–118. 2009.
|
|
14
|
Shih WL, Chang HC, Liaw YF, et al:
Influences of tobacco and alcohol use on hepatocellular carcinoma
survival. Int J Cancer. 131:2612–2621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: a study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Child CG and Turcotte JG: Surgery and
portal hypertension. Major Probl Clin Surg. 1:1–85. 1964.
|
|
17
|
No authors listed. A new prognostic system
for hepatocellular carcinoma: a retrospective study of 435
patients: the Cancer of the Liver Italian Program (CLIP)
investigators. Hepatology. 28:751–755. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sherman M: Approaches to the diagnosis of
hepatocellular carcinoma. Curr Gastroenterol Rep. 7:11–18. 2005.
View Article : Google Scholar
|
|
19
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar
|
|
20
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lawrie CH, Gal S, Dunlop HM, et al:
Detection of elevated levels of tumour-associated microRNAs in
serum of patients with diffuse large B-cell lymphoma. Br J
Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomimaru Y, Eguchi H, Nagano H, et al:
Circulating microRNA-21 as a novel biomarker for hepatocellular
carcinoma. J Hepatol. 56:167–175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bao W, Fu HJ, Xie QS, et al: HER2
interacts with CD44 to up-regulate CXCR4 via epigenetic silencing
of microRNA-139 in gastric cancer cells. Gastroenterology.
141:2076–2087. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen K, Liang Q, Xu K, et al: MiR-139
inhibits invasion and metastasis of colorectal cancer by targeting
the type I insulin-like growth factor receptor. Biochem Pharmacol.
84:320–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmitz KJ, Helwig J, Bertram S, et al:
Differential expression of microRNA-675, microRNA-139–3p and
microRNA-335 in benign and malignant adrenocortical tumours. J Clin
Pathol. 64:529–535. 2011.PubMed/NCBI
|
|
27
|
Corbetta S, Vaira V, Guarnieri V, et al:
Differential expression of microRNAs in human parathyroid
carcinomas compared with normal parathyroid tissue. Endocr Relat
Cancer. 17:135–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong CC, Wong CM, Tung EK, et al: The
microRNA miR-139 suppresses metastasis and progression of
hepatocellular carcinoma by down-regulating Rho-kinase 2.
Gastroenterology. 140:322–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Au SL, Wong CC, Lee JM, et al: Enhancer of
zeste homolog 2 epigenetically silences multiple tumor suppressor
microRNAs to promote liver cancer metastasis. Hepatology.
56:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ker CG, Chen HY, Chen KS, et al: Clinical
significance of cell differentiation in hepatocellular carcinoma.
Hepatogastroenterology. 50:475–479. 2003.PubMed/NCBI
|
